Tenofovir Disoproxil Fumarate Approved in Europe for Treatment of ... DG News - Moderate to severe adverse events occurring in more than 5% of patients receiving the medication included rash, headache, pain, diarrhoea, depression, ... |
Friday, April 25, 2008
Tenofovir Disoproxil Fumarate Approved in Europe for Treatment of ... - DG News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment